Spots Global Cancer Trial Database for Longitudinal Study of CRS/HIPEC for Peritoneal Carcinomatoses
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Longitudinal Study of CRS/HIPEC for Peritoneal Carcinomatoses
Official Title: Longitudinal Study of the Effect of Cytoreductive Surgery and HIPEC in Patients With Peritoneal Carcinomatoses
Study ID: NCT04108936
Conditions
Interventions
Study Description
Brief Summary: Longitudinal Study of the Effect of Cytoreductive Surgery and HIPEC in Patients With Peritoneal Carcinomatoses
Detailed Description: Cross-sectional and longitudinal analysis of cellular immune responses in the context of disease outcome. Cross-sectional and longitudinal analysis of the microbiome in the context of disease outcome. Analysis of renal function with respect of different HIPEC regimens Identification of clinical surrogate parameters for outcome.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Krankenhaus der Barmherzigen Brüder Regensburg, Regensburg, Bavaria, Germany
University Hospital Regensburg, Regensburg, , Germany
Contact Details
Name: Matthias Hornung, MD
Affiliation: Dept. of Surgery, University Hospital Regensburg
Role: STUDY_DIRECTOR
Name: Jens M Werner, MD
Affiliation: Dept. of Surgery, University Hospital Regensburg
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
